Abstract:BackgroundThe combination of primary aldosteronism (PA) and alterations in plasma renin activity (PRA) is a leading cause of secondary hypertension. An accurate measurement of Renin Angiotensin-Aldosterone System (RAAS) pathway improves the recognition of symptoms related to stroke, coronary disease, heart failure and metabolic syndrome.MethodsPreviously, surrogate matrices have been used when demonstrating the analytical performance of LC-MS/MS clinical research methods for the measurement of aldosterone and angiotensin I. Here, we have developed an analytically sensitive and reliable analytical strategy for simultaneous measurement of Aldosterone and Angiotensin I in human matrices. In-house calibrators and quality control samples were prepared, containing varying ranges of both aldosterone (20-2000pg/mL; 55-5548pmol/L) and angiotensin 1 (0.6-240ng/mL; 0.46-185nmol/L). The samples were extracted using the OasisTM MAX 96-well μElution plate and then separated through the ACQUITYTM UPLCTM I-Class FL System using a XBridgeTM Premier Peptide BEHTM C18 Column, over a run time of 3 minutes. Samples were then injected to XevoTM TQ Absolute Mass Spectrometer, using both positive and negative acquisition modes. The downstream LC-MS/MS data analysis was performed using MassLynxTM MS Software. The analytical performance was demonstrated by extracting and quantifying two replicates of samples on two occasions per day over five separate days. Additionally, the stability of aldosterone and angiotensin I over the period of incubation (3-5hr) was evaluated, which is necessary when investigating the plasma renin activity in human Serum/Plasma samples.ResultsHigh reproducibility and repeatability were both determined, indicating total precision and repeatability (<15%CV) for both analytes and no significant changes were found in Aldosterone and Angiotensin I concentrations over 3-5hr of incubation. No significant system carryover ( 0.992 for all analyses at different incubation times. The analytical sensitivity of the clinical research method allows for precise quantification at 55 pmol/L for aldosterone and 0.46 nmol/L/hr for angiotensin I, with both analytes providing S/N (PtP) ≥10:1 and %RSD of <15% at these concentrations.ConclusionsAn analytically sensitive and selective clinical research method has been developed for the analysis of aldosterone and angiotensin I, using the Xevo TQ Absolute Mass Spectrometer. The Xevo TQ Absolute Mass Spectrometer enables the simultaneous analysis of physiologically low levels of aldosterone and plasma renin activity in human samples, (20pg/mL; 55pmol/L), (0.6ng/mL; 0.46nmol/h/L). A single test that improves instrument utilization, reduces cost, and allows the user to expand their existing test menu on the same platform has been established.

Stable Plasma Sample Storage In Acetonitrile For Angiotensin And Aldosterone Analysis

Quality assurance of add-on testing in plasma samples: stability limit for 29 biochemical analytes

Stabilizing specimens for routine ammonia testing in the clinical laboratory

Add-on testing: stability assessment of 63 biochemical analytes in centrifuged and capped samples stored at 16 °C

Stability of adrenocorticotropic hormone in whole blood samples: effects of storage conditions

The stability of 65 biochemistry analytes in plasma, serum, and whole blood

Research on the stability changes in expert consensus of the ACTH detection preprocessing scheme

Characterizing the Stability of Angiotensin II in 0.9% Sodium Chloride Using High Performance Liquid Chromatography and Liquid Chromatography Tandem Mass Spectrometry

Influence of storage conditions on in vitro stability of atrial natriuretic peptide and of anesthesia on plasma atrial natriuretic peptide concentration in cats

A-067 Simultaneous Measurement of Aldosterone and Plasma Renin Activity in Human Serum Using Liquid Chromatography Coupled to Tandem Mass Spectrometry for Clinical Research

Study of the Stability of Various Biochemical Analytes in Samples Stored at Different Predefined Storage Conditions at an Accredited Laboratory of India

Insight into the status of plasma renin and aldosterone measurement: findings from 526 clinical laboratories in China

A-097 Stability Study of 21 Common Plasma Biochemistries in Unspun Whole Blood

AD plasma biomarkers are stable for an extended period at -20°C: implications for resource-constrained environments

Development of a LC-MS/MS Method for Determination of Plasma Aldosterone and Its Performance Evaluation

Total lab automation: sample stability of clinical chemistry parameters in an automated storage and retrieval module

The Clinical Impact of Sample Storage at −20 °C on Renin Reference Intervals and Aldosterone–Renin Ratio Calculations

Storage of plasma-derived exosomes: evaluation of anticoagulant use and preserving temperatures

An Isotope Dilution Liquid Chromatography-Tandem Mass Spectrometry Candidate Reference Measurement Procedure for Aldosterone Measurement in Human Plasma

Pre-Analytical Sample Quality: Metabolite Ratios as an Intrinsic Marker for Prolonged Room Temperature Exposure of Serum Samples

The influence of various sample storage conditions and sample bacterial contamination on concentrations of routine biochemical parameters